Literature DB >> 3108593

Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases.

L Guillevin, T Guittard, O Bletry, P Godeau, P Rosenthal.   

Abstract

Causes and precipitating factors for systemic necrotizing angiitis (NA) with asthma were sought in 43 patients, focusing on a history of vaccination and desensitization. Mean age of patients was 43.2 years. Diagnosis was based on histopathologic findings in 25 patients, arteriography in 2, and clinical criteria in 16. History of allergic manifestations (asthma, rhinitis, eczema, urticaria) was present in the family of 19 patients. Forty-two patients presented with asthma before development of NA and 23 of them were treated with steroids. Nineteen subjects gave a history of desensitization and 5 of vaccination in the 4 weeks preceding the disease. The main symptoms of NA were asthma in 43, fever in 25, weight loss in 31, peripheral neuropathy in 29, cutaneous signs in 25, digestive signs in 16 (abdominal pain, digestive bleeding, bowel perforation), noninfectious pneumopathy with pulmonary infiltrates in 33. Eosinophilia was 8,212 +/- 6,214/mm3. Antigen HBs was found in 2 of 30 patients. Prognosis of NA with asthma was good in 15 patients who recovered completely from the disease. Seven patients died and the other patients improved but remained under treatment. The survival curve showed that 75% of patients were alive after 60 months. Our findings suggest that different causes can be considered responsible for NA, and that, in cases of NA with asthma, there is reason to consider vaccination and desensitization as precipitating factors.

Entities:  

Mesh:

Year:  1987        PMID: 3108593     DOI: 10.1007/bf02714432

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  14 in total

1.  Polyarteritis nodosa; statistical review of one hundred seventy-five cases from the literature and report of a typical case.

Authors:  J W NUZUM
Journal:  AMA Arch Intern Med       Date:  1954-12

2.  The clinical manifestations of essential polyanglitis (periarteritis nodosa), with emphasis on the hepatic manifestations.

Authors:  F H MOWREY; E A LUNDBERG
Journal:  Ann Intern Med       Date:  1954-06       Impact factor: 25.391

3.  Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.

Authors:  J CHURG; L STRAUSS
Journal:  Am J Pathol       Date:  1951 Mar-Apr       Impact factor: 4.307

4.  Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa.

Authors:  A M Prince; C Trepo
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

5.  Necrotizing vasculitis after acute serous otitis media.

Authors:  J S Sergent; C L Christian
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

6.  [Responsibility of immune complexes in necrotizing angitis].

Authors:  L Guillevin
Journal:  Ann Med Interne (Paris)       Date:  1982

7.  Onset of polyarteritis nodosa during allergic hyposensitization treatment.

Authors:  P Phanuphak; P F Kohler
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

8.  The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa.

Authors:  C G Trepo; A J Zucherman; R C Bird; A M Prince
Journal:  J Clin Pathol       Date:  1974-11       Impact factor: 3.411

Review 9.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

10.  The spectrum of eosinophilic infiltration of the gastrointestinal tract and its relationship to other disorders of angiitis and granulomatosis.

Authors:  K C Suen; J D Burton
Journal:  Hum Pathol       Date:  1979-01       Impact factor: 3.466

View more
  12 in total

Review 1.  Churg-Strauss syndrome.

Authors:  M Conron; H L Beynon
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus.

Authors:  C Serna-Candel; O Moreno-Perez; V Soriano; A Martínez
Journal:  Clin Rheumatol       Date:  2007-08-03       Impact factor: 2.980

Review 3.  Pulmonary vasculitis.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2006

Review 4.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 5.  French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).

Authors:  Benjamin Terrier; Raphaël Darbon; Cécile-Audrey Durel; Eric Hachulla; Alexandre Karras; Hélène Maillard; Thomas Papo; Xavier Puechal; Grégory Pugnet; Thomas Quemeneur; Maxime Samson; Camille Taille; Loïc Guillevin
Journal:  Orphanet J Rare Dis       Date:  2020-12-29       Impact factor: 4.123

Review 6.  Vasculitis for the internist: focus on ANCA-associated vasculitis.

Authors:  Benjamin Chaigne; Loïc Guillevin
Journal:  Intern Emerg Med       Date:  2017-06-16       Impact factor: 3.397

Review 7.  Eosinophils in the 1990s: new perspectives on their role in health and disease.

Authors:  A J Wardlaw
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

8.  Serum cytokine changes in systemic vasculitis.

Authors:  G E Grau; P Roux-Lombard; C Gysler; C Lambert; P H Lambert; J M Dayer; L Guillevin
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

9.  Churg-strauss syndrome and active chronic hepatitis B virus infection: coincidence or association?

Authors:  Diogo Souza Domiciano; Samuel Katsuyuki Shinjo; Maurício Levy-Neto
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

Review 10.  Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.

Authors:  Loïc Raffray; Loïc Guillevin
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.